WOOJUNG BIO, Inc. (KOSDAQ:215380)
South Korea
· Delayed Price · Currency is KRW 3,015.00
-95.00 (-3.05%)
At close: Apr 28, 2026
WOOJUNG BIO Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 50,741 | 29,637 | 28,610 | 27,081 | 38,678 | 80,970 | Upgrade
|
| Market Cap Growth | 106.51% | 3.59% | 5.65% | -29.98% | -52.23% | -29.00% | Upgrade
|
| Enterprise Value | 97,145 | 78,865 | 75,576 | 84,550 | 87,971 | 116,281 | Upgrade
|
| Last Close Price | 3015.00 | 1761.00 | 1700.00 | 2090.00 | 2985.00 | 6290.00 | Upgrade
|
| PE Ratio | - | - | 126.99 | - | - | - | Upgrade
|
| PS Ratio | 1.35 | 0.79 | 0.66 | 0.70 | 0.82 | 2.59 | Upgrade
|
| PB Ratio | 2.17 | 1.27 | 0.97 | 1.23 | 1.30 | 2.54 | Upgrade
|
| P/TBV Ratio | 2.26 | 1.32 | 1.00 | 1.29 | 1.35 | 2.66 | Upgrade
|
| P/OCF Ratio | - | - | - | - | 15.46 | 46.86 | Upgrade
|
| EV/Sales Ratio | 2.58 | 2.10 | 1.75 | 2.19 | 1.88 | 3.72 | Upgrade
|
| EV/EBITDA Ratio | - | 674.42 | 12.63 | 283.56 | 50.98 | - | Upgrade
|
| EV/EBIT Ratio | - | - | 42.35 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 2.16 | 2.16 | 1.74 | 2.38 | 1.37 | 1.22 | Upgrade
|
| Debt / EBITDA Ratio | 432.05 | 432.05 | 8.52 | 175.46 | 23.58 | - | Upgrade
|
| Net Debt / Equity Ratio | 1.99 | 1.99 | 1.58 | 2.12 | 1.20 | 1.01 | Upgrade
|
| Net Debt / EBITDA Ratio | 396.82 | 396.82 | 7.77 | 156.18 | 20.68 | -27.71 | Upgrade
|
| Net Debt / FCF Ratio | -52.47 | -52.47 | -32.80 | -11.46 | -4.00 | -0.92 | Upgrade
|
| Asset Turnover | 0.41 | 0.41 | 0.45 | 0.40 | 0.48 | 0.37 | Upgrade
|
| Inventory Turnover | 4.26 | 4.26 | 6.58 | 8.19 | 10.10 | 6.25 | Upgrade
|
| Quick Ratio | 0.26 | 0.26 | 0.33 | 0.28 | 0.17 | 0.35 | Upgrade
|
| Current Ratio | 0.57 | 0.57 | 0.64 | 0.43 | 0.31 | 0.67 | Upgrade
|
| Return on Equity (ROE) | -21.03% | -21.03% | 0.88% | -19.55% | -6.10% | -5.91% | Upgrade
|
| Return on Assets (ROA) | -2.52% | -2.52% | 1.16% | -2.60% | -1.62% | -2.84% | Upgrade
|
| Return on Invested Capital (ROIC) | -5.09% | -5.02% | 2.47% | -6.01% | -3.89% | -7.23% | Upgrade
|
| Return on Capital Employed (ROCE) | -6.40% | -6.40% | 2.80% | -7.60% | -5.10% | -6.20% | Upgrade
|
| Earnings Yield | -10.93% | -18.71% | 0.79% | -18.66% | -4.86% | -2.38% | Upgrade
|
| FCF Yield | -1.74% | -2.98% | -4.96% | -15.01% | -23.06% | -43.17% | Upgrade
|
| Buyback Yield / Dilution | -10.89% | -10.90% | 4.46% | -22.07% | -7.66% | -3.36% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.